Targeting the tyrosine kinase signalling pathways for treatment of immune-mediated glomerulonephritis: from bench to bedside and beyond

Glomerulonephritis (GN) affects patients of all ages and is an important cause of morbidity and mortality. Non-selective immunosuppressive drugs have been used in immune-mediated GN but often result in systemic side effects and occasionally fatal infective complications. There is increasing evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Terry King-Wing, McAdoo, Stephen P., Tam, Frederick Wai Keung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410974/
https://www.ncbi.nlm.nih.gov/pubmed/28391340
http://dx.doi.org/10.1093/ndt/gfw336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410974/
https://www.ncbi.nlm.nih.gov/pubmed/28391340
http://dx.doi.org/10.1093/ndt/gfw336

Ejemplares similares